glp-1 use Agonists - What is it? GLP-1 and Anesthesia: Considerations and
Description
The science and data is undeniable
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
Over time, some patients may need to pause or stop therapy due to side effects, plateaus, or changing goals
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
For food and beverage companies, understanding how their use might evolve will be critical to staying relevant, from reformulating products to meeting new nutritional needs
| 40 comments on LinkedIn
